CD63 has significant clinical implications. It serves as a biomarker for various diseases, including some types of cancer and immune disorders. For example, elevated levels of CD63 in plasma have been associated with certain tumors. In addition, abnormalities in CD63 expression or function can lead to disorders such as bleeding disorders and inflammatory diseases. Therefore, understanding CD63's role in pathology can aid in the development of new therapeutic strategies.
